Compound 463
Identifiers
- Canonical SMILES:
COC(=O)[C@H](Cc1ccc(cc1)C#Cc1ccccc1)NC(=O)C[C@H]1CCCN(C1)C(N)=N
- IUPAC name:
methyl 2-[[2-(1-carbamimidoylpiperidin-3-yl)acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate
- InChi:
InChI=1S/C26H30N4O3/c1-33-25(32)23(29-24(31)17-22-8-5-15-30(18-22)26(27)28)16-21-13-11-20(12-14-21)10-9-19-6-3-2-4-7-19/h2-4,6-7,11-14,22-23H,5,8,15-18H2,1H3,(H3,27,28)(H,29,31)/t22-,23+/m1/s1
- InChiKey:
MRNGXYMKYHNMLV-PKTZIBPZSA-N
External links
5288250 |
CHEMBL419362 |
4450451 |
FRG |
DB03453 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
IL2 / IL2R | 5.52 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 446.23 g/mol | |||
HBA | 7 | |||
HBD | 4 | |||
HBA + HBD | 11 | |||
AlogP | 2.63 | |||
TPSA | 108.51 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
1.0000 | Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate | DB03453 | |
0.6462 | PZ-128 | DB11839 | |
0.6372 | Nateglinide | DB00731 | |
0.6364 | Aspartame | DB00168 | |
0.6299 | methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate | DB08505 | |
0.6241 | Bradykinin | DB12126 | |
0.6239 | N-DODECANOYL-L-TYROSINE | DB08275 | |
0.6183 | Antipain | DB15251 | |
0.6111 | Brimapitide | DB15231 | |
0.6077 | Skf 107457 | DB04191 | |
0.5865 | talactoferrin alpha | DB05426 | |
0.5839 | Cilengitide | DB11890 | |
0.5833 | Soblidotin | DB12677 | |
0.5790 | BIO-11006 | DB14886 | |
0.5743 | Argifin | DB03632 |